Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

By sjmartinez • August 31, 2023

Chew KW, Moser C, Yeh E, Wohl DA, Daar ES, Ritz J, Javan AC, Eron JJ, Currier JS, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial. J Infect Dis. 2023 Aug 31;228(Supplement_2):S83-S91. doi: 10.1093/infdis/jiad300. PMID: 37650237; PMCID: PMC10469584.

Tags: ACTIV-2, covid-19, Harbor UCLA, Infectious Diseases, internal validity, patient-reported outcomes, Publications, symptom diary, time to symptom resolution

Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study

Wang FM, Ballew SH, Folsom AR, Wagenknecht LE, Howard CM, Coresh J, Budoff MJ, Blaha MJ, Matsushita K. Mid- to Late-Life Traditional Cardiovascular Risk Factor[...]

South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population – An American society for preventive cardiology clinical practice statement

Rohatgi A, Anand SS, Gadgil M, Gujral UP, Jain SS, Javed Z, Jha M, Joshi PH, Manubolu VS, Nasir K, Natarajan P, Pagidipati N, Palaniappan[...]

Sleep Patterns, Symptoms, and Mortality in Hemodialysis: A Prospective Cohort Study

Narasaki Y, You AS, Kurtz I, Nobakht N, Kamgar M, Siu MKM, Ahdoot RS, Hanna R, Kalantar SS, Yoon J, Le L, Torres Rivera S,[...]